Wordt geladen...
The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor
BACKGROUND: An increasing number of patients are treated with direct-acting oral anticoagulants (DOACs), but the optimal way to reverse the anticoagulant effect is not known. Specific antidotes are not available and prothrombin complex concentrate (PCC), activated PCC (aPCC) and recombinant factor V...
Bewaard in:
| Gepubliceerd in: | Thromb J |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5319105/ https://ncbi.nlm.nih.gov/pubmed/28239301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12959-017-0129-1 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|